Status:
COMPLETED
Association Between Tumor Size and Prognosis in Patients With Small Bowel adenocarcinoma-a SEER-based Study
Lead Sponsor:
Zhe Fan
Conditions:
Prognosis
Eligibility:
All Genders
Brief Summary
The goal of this observational study is to learn about in small bowel adenocarcinoma patients. The main question it aims to answer is the association between tumor size and prognosis in patients with ...
Eligibility Criteria
Inclusion
- pathology confirmed as SBA;
- received surgery and complete postoperative follow-up data;
- histology type code 8140-8380.
Exclusion
- Cases with unknown tumor location, size, TNM staging, race, and degree of differentiation were excluded. Finally, 8,163 eligible patients were included in the analysis
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
8163 Patients enrolled
Trial Details
Trial ID
NCT06087887
Start Date
January 1 2023
End Date
October 1 2023
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dalian Third People's Hospital Affiliated to Dalian Medical University
Dalian, Liaoning, China